Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8247532
Deuterated hepatitis C protease inhibitors
granted -
US 8242080
Inhibitors of the EGFR kinase targeting the asymmetric activating dimer interface
granted -
US 8242160
Inhibitors of ubiquitin E1
granted -
US 8242170
Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy
granted -
US 8242112
Heterocyclic aspartyl protease inhibitors
granted -
US 8236807
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
granted -
US 8236835
Heterocyclic inhibitors of stearoyl-CoA desaturase
granted -
US 8236832
Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
granted -
US 8232406
c-MET protein kinase inhibitors
granted -
US 8227516
Compounds as histone deacetylase inhibitors
granted -
US 8222288
Small molecule inhibitors of MDM2 and the uses thereof
granted -
US 8222215
Methods for the use of inhibitors of antigen presentation by MHC class II molecules
granted -
US 8221737
Hepatitis C virus inhibitors
granted -
US 8222293
Treating learning deficits with inhibitors of Hmg CoA reductase
granted -
US 8222411
Dipeptidyl peptidase inhibitors
granted -
US 8222203
Macrocyclic oximyl hepatitis C serine protease inhibitors
granted -
US 8217048
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted -
US 8211891
Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors
granted -
US 8211914
Inhibitors of diacylglycerol acyltransferase
granted -
US 8211884
Diacylglycerol acyltransferase inhibitors
granted -
US 8202861
Compositions useful as inhibitors of voltage-gated sodium channels
granted -
US 8202990
Polo-like kinase inhibitors
granted -
US 8202889
Inhibitors of bacterial IMPDH
granted -
US 8193202
LIMK2 inhibitors, compositions comprising them, and methods of their use
granted